FOURPATH CAPITAL MANAGEMENT, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1894484 OKLAHOMA CITY, OK

Position in VRTX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$679,526

-$73,786 QoQ

Shares Held

1,368

-18.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#968

of 1,735 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOURPATH CAPITAL MANAGEMENT, LLC holds $879,710 across 2 Biotechnology names. VRTX ranks #1 (77.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,368	$679,526
2	ALNY	Alnylam Pharmaceuticals, Inc.	665	$200,184

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,526	1,368	-18.9%	Shares	Sole	2026-07-22
2026-03-31	$753,312	1,687	-4.6%	Shares	Sole	2026-05-01
2025-12-31	$801,540	1,768	+6.6%	Shares	Sole	2026-01-23
2025-09-30	$649,730	1,659	+20.3%	Shares	Sole	2025-10-14
2025-06-30	$613,930	1,379	-12.0%	Shares	Sole	2025-07-24
2025-03-31	$759,712	1,567	-7.7%	Shares	Sole	2025-04-15
2024-12-31	$683,381	1,697	-0.1%	Shares	Sole	2025-01-24
2024-09-30	$790,170	1,699	+1.8%	Shares	Sole	2024-11-08
2024-06-30	$782,293	1,669	-8.8%	Shares	Sole	2024-08-02
2024-03-31	$764,958	1,830	-3.9%	Shares	Sole	2024-05-07
2023-12-31	$775,125	1,905	-6.7%	Shares	Sole	2024-04-08
2023-09-30	$709,737	2,041	-2.7%	Shares	Sole	2023-11-13
2023-06-30	$737,955	2,097	-1.5%	Shares	Sole	2023-08-07
2023-03-31	$670,784	2,129	-1.3%	Shares	Sole	2023-05-10
2022-12-31	$622,609	2,156	-3.2%	Shares	Sole	2023-02-06
2022-09-30	$644,805	2,227	-21.1%	Shares	Sole	2022-11-04
2022-06-30	$795,493	2,823	-21.4%	Shares	Sole	2022-08-09
2022-03-31	$937,404	3,592	-9.0%	Shares	Sole	2022-04-14
2021-12-31	$866,541	3,946	—	Shares	Sole	2022-01-25
No filing history on record for this holder in this stock.